Core Scientific (CORZ) Cost of Revenue (2021 - 2026)

Core Scientific has disclosed Cost of Revenue across 6 years of filings, most recently posting $85.1 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $85.1 million, up 19.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $294.9 million (down 17.9% YoY), and the FY2025 annual result was $281.1 million, down 27.84% from the prior year.
• Cost of Revenue came in at $85.1 million for Q1 2026 at Core Scientific, up from $59.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $375.8 million in Q4 2023 to a low of -$450.7 million in Q4 2022.
• The 5-year median for Cost of Revenue is $77.2 million (2025), against an average of $57.3 million.
• Across the five-year window, Cost of Revenue sank 219.34% in 2022 and soared 9335.89% in 2024, its largest moves.
• Core Scientific's Cost of Revenue stood at -$450.7 million in 2022, then jumped by 183.39% to $375.8 million in 2023, then plunged by 76.01% to $90.2 million in 2024, then tumbled by 34.55% to $59.0 million in 2025, then surged by 44.28% to $85.1 million in 2026.
• The last three Cost of Revenue figures came in at $85.1 million (Q1 2026), $59.0 million (Q4 2025), and $77.2 million (Q3 2025), per Business Quant data.